PDB Short entry for 1H1B HEADER HYDROLASE 05-JUL-02 1H1B TITLE CRYSTAL STRUCTURE OF HUMAN NEUTROPHIL ELASTASE COMPLEXED WITH AN TITLE 2 INHIBITOR (GW475151) COMPND MOL_ID: 1; COMPND 2 MOLECULE: LEUKOCYTE ELASTASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ELASTASE, NEUTROPHIL ELASTASE, PMN ELASTASE, BONE MARROW COMPND 5 SERINE PROTEASE, MEDULLASIN; COMPND 6 EC: 3.4.21.37 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 CELL: LEUKOCYTE KEYWDS HYDROLASE, SERINE PROTEASE EXPDTA X-RAY DIFFRACTION AUTHOR S.J.F.MACDONALD,M.D.DOWLE,L.A.HARRISON,G.D.E.CLARKE,G.G.A.INGLIS, AUTHOR 2 M.R.JOHNSON,R.A.SMITH,A.AMOUR,G.FLEETWOOD,D.C.HUMPHREYS,C.R.MOLLOY, AUTHOR 3 M.DIXON,R.E.GODWARD,A.J.WONACOTT,O.M.P.SINGH,S.T.HODGSON,G.W.HARDY REVDAT 7 13-DEC-23 1H1B 1 HETSYN LINK REVDAT 6 29-JUL-20 1H1B 1 COMPND REMARK HETNAM LINK REVDAT 6 2 1 SITE ATOM REVDAT 5 08-MAY-19 1H1B 1 REMARK LINK REVDAT 4 14-SEP-11 1H1B 1 KEYWDS REMARK HETSYN FORMUL REVDAT 4 2 1 SHEET SITE VERSN REVDAT 3 24-FEB-09 1H1B 1 VERSN REVDAT 2 24-JUN-03 1H1B 1 HETNAM LINK ATOM TER REVDAT 2 2 1 HETATM CONECT REVDAT 1 29-AUG-02 1H1B 0 JRNL AUTH S.J.F.MACDONALD,M.D.DOWLE,L.A.HARRISON,G.D.E.CLARKE, JRNL AUTH 2 G.G.A.INGLIS,M.R.JOHNSON,P.SHAH,R.A.SMITH,A.AMOUR, JRNL AUTH 3 G.FLEETWOOD,D.C.HUMPHREYS,C.R.MOLLOY,M.DIXON,R.E.GODWARD, JRNL AUTH 4 A.J.WONACOTT,O.M.P.SINGH,S.T.HODGSON,G.W.HARDY JRNL TITL DISCOVERY OF FURTHER PYRROLIDINE TRANS-LACTAMS AS INHIBITORS JRNL TITL 2 OF HUMAN NEUTROPHIL ELASTASE (HNE) WITH POTENTIAL AS JRNL TITL 3 DEVELOPMENT CANDIDATES AND THE CRYSTAL STRUCTURE OF HNE JRNL TITL 4 COMPLEXED WITH AN INHIBITOR (GW475151) JRNL REF J.MED.CHEM. V. 45 3878 2002 JRNL REFN ISSN 0022-2623 JRNL PMID 12190311 JRNL DOI 10.1021/JM020881F REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 96.0 REMARK 3 NUMBER OF REFLECTIONS : 36959 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.254 REMARK 3 R VALUE (WORKING SET) : 0.251 REMARK 3 FREE R VALUE : 0.310 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1948 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3272 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 154 REMARK 3 SOLVENT ATOMS : 244 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 41.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.33000 REMARK 3 B22 (A**2) : -0.33000 REMARK 3 B33 (A**2) : 0.67000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.210 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.199 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.179 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 6.500 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1H1B COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 05-JUL-02. REMARK 100 THE DEPOSITION ID IS D_1290009885. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-OCT-99 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 4.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SRS REMARK 200 BEAMLINE : PX9.6 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.87 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38930 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.1 REMARK 200 DATA REDUNDANCY : 6.400 REMARK 200 R MERGE (I) : 0.08800 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 11.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.10 REMARK 200 COMPLETENESS FOR SHELL (%) : 83.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.52000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1HNE REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.89 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.07 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: HNE/GW475151 COMPLEX 10MG/ML IN 10MM REMARK 280 NA CITRATE PH 5.0. HANGING DROPS OF EQUAL VOLUMES OF PROTEIN AND REMARK 280 PRECIPITANT. PRECIPITANT 1.1-1.2M AMMONIUM SULPHATE, 100MM REMARK 280 CITRATE PH 3.8-4.0, ROOM TEMP., PH 4.00, VAPOR DIFFUSION, REMARK 280 HANGING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y,X,Z+3/4 REMARK 290 4555 Y,-X,Z+1/4 REMARK 290 5555 -X,Y,-Z REMARK 290 6555 X,-Y,-Z+1/2 REMARK 290 7555 Y,X,-Z+1/4 REMARK 290 8555 -Y,-X,-Z+3/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 120.57500 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 180.86250 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 60.28750 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 120.57500 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 60.28750 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 180.86250 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1650 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 22370 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -19.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NH1 ARG A 147 O HOH A 2086 1.53 REMARK 500 NE2 GLN B 122 O HOH B 2058 1.74 REMARK 500 CD GLN B 122 O HOH B 2058 1.89 REMARK 500 OE1 GLN B 122 O HOH B 2058 1.91 REMARK 500 O ALA B 60 O HOH B 2019 1.96 REMARK 500 OG SER A 153 O HOH A 2087 1.97 REMARK 500 OD1 ASN A 132 O HOH A 2082 2.01 REMARK 500 O HOH B 2007 O HOH B 2020 2.01 REMARK 500 OE1 GLN B 122 O HOH B 2057 2.03 REMARK 500 ND2 ASN B 236 O HOH B 2099 2.05 REMARK 500 OD1 ASN B 132 O HOH B 2062 2.05 REMARK 500 NH2 ARG B 186 O HOH B 2076 2.08 REMARK 500 O ARG A 178 O HOH A 2095 2.13 REMARK 500 OD2 ASP A 226 O HOH A 2126 2.13 REMARK 500 O HOH A 2058 O HOH A 2129 2.13 REMARK 500 OD1 ASN B 72 OG SER B 74 2.13 REMARK 500 O3 151 A 400 O HOH A 2136 2.16 REMARK 500 O HOH B 2047 O HOH B 2103 2.17 REMARK 500 O HOH A 2135 O HOH B 2025 2.17 REMARK 500 OXT GLN B 243 O HOH B 2103 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 2042 O HOH B 2020 7555 1.60 REMARK 500 NH2 ARG A 147 NH2 ARG A 147 7555 1.71 REMARK 500 O HOH B 2057 O HOH B 2057 5655 2.00 REMARK 500 O HOH A 2042 O HOH B 2007 7555 2.03 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 CYS A 182 CA - CB - SG ANGL. DEV. = 13.1 DEGREES REMARK 500 LEU B 100 CA - CB - CG ANGL. DEV. = 17.9 DEGREES REMARK 500 CYS B 182 CA - CB - SG ANGL. DEV. = 9.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 71 -67.61 -127.73 REMARK 500 ASN A 115 -159.94 -159.32 REMARK 500 ARG A 128 92.38 -66.28 REMARK 500 ARG A 147 2.18 140.63 REMARK 500 ARG A 149 141.48 69.74 REMARK 500 SER A 214 -58.24 -122.17 REMARK 500 PRO B 24 113.60 -30.28 REMARK 500 ARG B 36 -133.07 72.86 REMARK 500 ASN B 61 59.07 -140.14 REMARK 500 HIS B 71 -44.52 -139.21 REMARK 500 ASN B 115 -158.27 -140.95 REMARK 500 ASN B 132 129.32 -37.11 REMARK 500 ARG B 147 -8.46 144.87 REMARK 500 ARG B 149 141.22 89.34 REMARK 500 SER B 214 -53.30 -124.64 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2017 DISTANCE = 6.84 ANGSTROMS REMARK 700 REMARK 700 SHEET REMARK 700 DETERMINATION METHOD: DSSP REMARK 700 THE SHEETS PRESENTED AS "AA" IN EACH CHAIN ON SHEET RECORDS REMARK 700 BELOW IS ACTUALLY AN 8-STRANDED BARREL THIS IS REPRESENTED BY REMARK 700 A 9-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS REMARK 700 ARE IDENTICAL. REMARK 700 THE SHEETS PRESENTED AS "AB" IN EACH CHAIN ON SHEET RECORDS REMARK 700 BELOW IS ACTUALLY AN 14-STRANDED BARREL THIS IS REPRESENTED BY REMARK 700 A 15-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS REMARK 700 ARE IDENTICAL. REMARK 700 THE SHEETS PRESENTED AS "BA" IN EACH CHAIN ON SHEET RECORDS REMARK 700 BELOW IS ACTUALLY AN 6-STRANDED BARREL THIS IS REPRESENTED BY REMARK 700 A 7-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS REMARK 700 ARE IDENTICAL. REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1B0F RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN NEUTROPHIL ELASTASE WITH MDL 101, 146 REMARK 900 RELATED ID: 1HNE RELATED DB: PDB REMARK 900 HUMAN NEUTROPHIL ELASTASE (HNE) (ALSO REFERRED TO AS HUMAN REMARK 900 LEUCOCYTE ELASTASE (HLE)) COMPLEX WITH METHOXYSUCCINYL-ALA-ALA-PRO- REMARK 900 ALA CHLOROMETHYL KETONE (MSACK) REMARK 900 RELATED ID: 1PPF RELATED DB: PDB REMARK 900 HUMAN LEUKOCYTE ELASTASE (HLE) (NEUTROPHIL ELASTASE (HNE)) COMPLEX REMARK 900 WITH THE THIRD DOMAIN OF TURKEY OVOMUCOID INHIBITOR (OMTKY3) REMARK 900 RELATED ID: 1PPG RELATED DB: PDB REMARK 900 HUMAN LEUKOCYTE ELASTASE (HLE) COMPLEX WITH MEO-SUCCINYL-ALA-ALA- REMARK 900 PRO-VAL CHLOROMETHYLACETONE DBREF 1H1B A 16 36 UNP P08246 ELNE_HUMAN 30 50 DBREF 1H1B A 38 92 UNP P08246 ELNE_HUMAN 51 108 DBREF 1H1B A 94 95 UNP P08246 ELNE_HUMAN 109 110 DBREF 1H1B A 98 145 UNP P08246 ELNE_HUMAN 111 160 DBREF 1H1B A 147 160 UNP P08246 ELNE_HUMAN 161 174 DBREF 1H1B A 162 168 UNP P08246 ELNE_HUMAN 175 183 DBREF 1H1B A 177 201 UNP P08246 ELNE_HUMAN 184 200 DBREF 1H1B A 204 205 UNP P08246 ELNE_HUMAN 201 202 DBREF 1H1B A 208 243 UNP P08246 ELNE_HUMAN 203 247 DBREF 1H1B B 16 36 UNP P08246 ELNE_HUMAN 30 50 DBREF 1H1B B 38 92 UNP P08246 ELNE_HUMAN 51 108 DBREF 1H1B B 94 95 UNP P08246 ELNE_HUMAN 109 110 DBREF 1H1B B 98 145 UNP P08246 ELNE_HUMAN 111 160 DBREF 1H1B B 147 160 UNP P08246 ELNE_HUMAN 161 174 DBREF 1H1B B 162 168 UNP P08246 ELNE_HUMAN 175 183 DBREF 1H1B B 177 201 UNP P08246 ELNE_HUMAN 184 200 DBREF 1H1B B 204 205 UNP P08246 ELNE_HUMAN 201 202 DBREF 1H1B B 208 243 UNP P08246 ELNE_HUMAN 203 247 SEQRES 1 A 218 ILE VAL GLY GLY ARG ARG ALA ARG PRO HIS ALA TRP PRO SEQRES 2 A 218 PHE MET VAL SER LEU GLN LEU ARG GLY GLY HIS PHE CYS SEQRES 3 A 218 GLY ALA THR LEU ILE ALA PRO ASN PHE VAL MET SER ALA SEQRES 4 A 218 ALA HIS CYS VAL ALA ASN VAL ASN VAL ARG ALA VAL ARG SEQRES 5 A 218 VAL VAL LEU GLY ALA HIS ASN LEU SER ARG ARG GLU PRO SEQRES 6 A 218 THR ARG GLN VAL PHE ALA VAL GLN ARG ILE PHE GLU ASN SEQRES 7 A 218 GLY TYR ASP PRO VAL ASN LEU LEU ASN ASP ILE VAL ILE SEQRES 8 A 218 LEU GLN LEU ASN GLY SER ALA THR ILE ASN ALA ASN VAL SEQRES 9 A 218 GLN VAL ALA GLN LEU PRO ALA GLN GLY ARG ARG LEU GLY SEQRES 10 A 218 ASN GLY VAL GLN CYS LEU ALA MET GLY TRP GLY LEU LEU SEQRES 11 A 218 GLY ARG ASN ARG GLY ILE ALA SER VAL LEU GLN GLU LEU SEQRES 12 A 218 ASN VAL THR VAL VAL THR SER LEU CYS ARG ARG SER ASN SEQRES 13 A 218 VAL CYS THR LEU VAL ARG GLY ARG GLN ALA GLY VAL CYS SEQRES 14 A 218 PHE GLY ASP SER GLY SER PRO LEU VAL CYS ASN GLY LEU SEQRES 15 A 218 ILE HIS GLY ILE ALA SER PHE VAL ARG GLY GLY CYS ALA SEQRES 16 A 218 SER GLY LEU TYR PRO ASP ALA PHE ALA PRO VAL ALA GLN SEQRES 17 A 218 PHE VAL ASN TRP ILE ASP SER ILE ILE GLN SEQRES 1 B 218 ILE VAL GLY GLY ARG ARG ALA ARG PRO HIS ALA TRP PRO SEQRES 2 B 218 PHE MET VAL SER LEU GLN LEU ARG GLY GLY HIS PHE CYS SEQRES 3 B 218 GLY ALA THR LEU ILE ALA PRO ASN PHE VAL MET SER ALA SEQRES 4 B 218 ALA HIS CYS VAL ALA ASN VAL ASN VAL ARG ALA VAL ARG SEQRES 5 B 218 VAL VAL LEU GLY ALA HIS ASN LEU SER ARG ARG GLU PRO SEQRES 6 B 218 THR ARG GLN VAL PHE ALA VAL GLN ARG ILE PHE GLU ASN SEQRES 7 B 218 GLY TYR ASP PRO VAL ASN LEU LEU ASN ASP ILE VAL ILE SEQRES 8 B 218 LEU GLN LEU ASN GLY SER ALA THR ILE ASN ALA ASN VAL SEQRES 9 B 218 GLN VAL ALA GLN LEU PRO ALA GLN GLY ARG ARG LEU GLY SEQRES 10 B 218 ASN GLY VAL GLN CYS LEU ALA MET GLY TRP GLY LEU LEU SEQRES 11 B 218 GLY ARG ASN ARG GLY ILE ALA SER VAL LEU GLN GLU LEU SEQRES 12 B 218 ASN VAL THR VAL VAL THR SER LEU CYS ARG ARG SER ASN SEQRES 13 B 218 VAL CYS THR LEU VAL ARG GLY ARG GLN ALA GLY VAL CYS SEQRES 14 B 218 PHE GLY ASP SER GLY SER PRO LEU VAL CYS ASN GLY LEU SEQRES 15 B 218 ILE HIS GLY ILE ALA SER PHE VAL ARG GLY GLY CYS ALA SEQRES 16 B 218 SER GLY LEU TYR PRO ASP ALA PHE ALA PRO VAL ALA GLN SEQRES 17 B 218 PHE VAL ASN TRP ILE ASP SER ILE ILE GLN MODRES 1H1B ASN A 109 ASN GLYCOSYLATION SITE MODRES 1H1B ASN A 159 ASN GLYCOSYLATION SITE MODRES 1H1B ASN B 109 ASN GLYCOSYLATION SITE MODRES 1H1B ASN B 159 ASN GLYCOSYLATION SITE HET NAG C 1 14 HET FUC C 2 10 HET NAG D 1 14 HET FUC D 2 10 HET NAG E 1 14 HET FUC E 2 10 HET NAG F 1 14 HET FUC F 2 10 HET 151 A 400 29 HET 151 B 400 29 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM FUC ALPHA-L-FUCOPYRANOSE HETNAM 151 (2S)-3-METHYL-2-((2R,3S)-3-[(METHYLSULFONYL)AMINO]-1- HETNAM 2 151 {[2-(PYRROLIDIN-1-YLMETHYL)-1,3-OXAZOL-4- HETNAM 3 151 YL]CARBONYL}PYRROLIDIN-2-YL)BUTANOIC ACID HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN FUC ALPHA-L-FUCOSE; 6-DEOXY-ALPHA-L-GALACTOPYRANOSE; L- HETSYN 2 FUC FUCOSE; FUCOSE FORMUL 3 NAG 4(C8 H15 N O6) FORMUL 3 FUC 4(C6 H12 O5) FORMUL 7 151 2(C19 H30 N4 O6 S) FORMUL 9 HOH *244(H2 O) HELIX 1 1 ALA A 55 ASN A 61 1 7 HELIX 2 2 ASN A 62A ARG A 63 5 3 HELIX 3 3 PHE A 234 GLN A 243 1 10 HELIX 4 4 ALA B 55 ALA B 60 1 6 HELIX 5 5 ASN B 62A ALA B 64 5 4 HELIX 6 6 PHE B 234 GLN B 243 1 10 SHEET 1 AA 9 ARG A 20 ARG A 21 0 SHEET 2 AA 9 GLN A 156 VAL A 163 -1 O GLU A 157 N ARG A 20 SHEET 3 AA 9 VAL A 181 LEU A 184 -1 O LEU A 184 N THR A 162 SHEET 4 AA 9 ASP A 226 PRO A 230 -1 O ASP A 226 N THR A 183 SHEET 5 AA 9 LEU A 208 PHE A 215 -1 O ILE A 212 N ALA A 229 SHEET 6 AA 9 PRO A 198 CYS A 201 -1 O LEU A 199 N HIS A 210 SHEET 7 AA 9 GLN A 135 GLY A 140 -1 O LEU A 137 N VAL A 200 SHEET 8 AA 9 GLN A 156 VAL A 163 1 O GLN A 156 N GLY A 140 SHEET 9 AA 9 ARG A 20 ARG A 21 -1 O ARG A 20 N GLU A 157 SHEET 1 AB15 MET A 30 LEU A 35 0 SHEET 2 AB15 GLY A 39 ALA A 48 -1 O GLY A 39 N LEU A 35 SHEET 3 AB15 PHE A 51 SER A 54 -1 O PHE A 51 N ILE A 47 SHEET 4 AB15 VAL A 104 LEU A 108 -1 O VAL A 104 N SER A 54 SHEET 5 AB15 VAL A 85 TYR A 94 -1 N GLN A 86 O GLN A 107 SHEET 6 AB15 GLN B 81 TYR B 94 -1 O ILE B 88 N TYR A 94 SHEET 7 AB15 VAL B 104 LEU B 108 -1 O ILE B 105 N PHE B 89 SHEET 8 AB15 PHE B 51 SER B 54 -1 O VAL B 52 N LEU B 106 SHEET 9 AB15 GLY B 39 ALA B 48 -1 O THR B 45 N MET B 53 SHEET 10 AB15 MET B 30 LEU B 35 -1 O VAL B 31 N ALA B 44 SHEET 11 AB15 ARG B 65A LEU B 68 -1 O ARG B 65A N GLN B 34 SHEET 12 AB15 GLN B 81 TYR B 94 1 O GLN B 81 N LEU B 68 SHEET 13 AB15 VAL A 85 TYR A 94 -1 O ILE A 88 N GLY B 92 SHEET 14 AB15 VAL A 104 LEU A 108 -1 O ILE A 105 N PHE A 89 SHEET 15 AB15 MET A 30 LEU A 35 0 SHEET 1 BA16 ARG B 20 ARG B 21 0 SHEET 2 BA16 GLN B 156 VAL B 164 -1 O GLU B 157 N ARG B 20 SHEET 3 BA16 VAL B 181 LEU B 184 -1 O CYS B 182 N VAL B 164 SHEET 4 BA16 ASP B 226 PRO B 230 -1 O ASP B 226 N THR B 183 SHEET 5 BA16 GLN B 135 GLY B 140 0 SHEET 6 BA16 GLN B 156 VAL B 164 1 O GLN B 156 N GLY B 140 SHEET 7 BA16 GLN B 156 VAL B 164 0 SHEET 8 BA16 ARG B 20 ARG B 21 -1 O ARG B 20 N GLU B 157 SHEET 9 BA16 VAL B 181 LEU B 184 0 SHEET 10 BA16 GLN B 156 VAL B 164 -1 O THR B 162 N LEU B 184 SHEET 11 BA16 PRO B 198 CYS B 201 0 SHEET 12 BA16 GLN B 135 GLY B 140 -1 O LEU B 137 N VAL B 200 SHEET 13 BA16 LEU B 208 PHE B 215 0 SHEET 14 BA16 PRO B 198 CYS B 201 -1 O LEU B 199 N HIS B 210 SHEET 15 BA16 ASP B 226 PRO B 230 0 SHEET 16 BA16 VAL B 181 LEU B 184 -1 O VAL B 181 N PHE B 228 SSBOND 1 CYS A 42 CYS A 58 1555 1555 2.05 SSBOND 2 CYS A 136 CYS A 201 1555 1555 2.04 SSBOND 3 CYS A 168 CYS A 182 1555 1555 2.07 SSBOND 4 CYS A 191 CYS A 220 1555 1555 1.97 SSBOND 5 CYS B 42 CYS B 58 1555 1555 2.04 SSBOND 6 CYS B 136 CYS B 201 1555 1555 2.04 SSBOND 7 CYS B 168 CYS B 182 1555 1555 2.03 SSBOND 8 CYS B 191 CYS B 220 1555 1555 1.95 LINK ND2 ASN A 109 C1 NAG D 1 1555 1555 1.46 LINK ND2 ASN A 159 C1 NAG C 1 1555 1555 1.42 LINK OG SER A 195 C30 151 A 400 1555 1555 1.54 LINK ND2 ASN B 109 C1 NAG F 1 1555 1555 1.47 LINK ND2 ASN B 159 C1 NAG E 1 1555 1555 1.45 LINK OG SER B 195 C30 151 B 400 1555 1555 1.39 LINK OG SER B 195 O5 151 B 400 1555 1555 2.03 LINK O6 NAG C 1 C1 FUC C 2 1555 1555 1.44 LINK O6 NAG D 1 C1 FUC D 2 1555 1555 1.44 LINK O6 NAG E 1 C1 FUC E 2 1555 1555 1.46 LINK O6 NAG F 1 C1 FUC F 2 1555 1555 1.43 CRYST1 68.880 68.880 241.150 90.00 90.00 90.00 P 43 2 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014518 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014518 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004147 0.00000 MTRIX1 1 -0.994520 0.003930 -0.104440 39.03800 1 MTRIX2 1 -0.004230 -0.999990 0.002680 -8.04100 1 MTRIX3 1 -0.104430 0.003110 0.994530 2.09500 1